Factors affecting central macular thickness of diabetic macular oedema patients after an induction treatment of intravitreal ranibizumab.

Md Tahir NursyafiqahSiti Azrin Ab HamidNajib Majdi YaacobWan-Adnan Wan-Nor-AsyikeenZunaina Embong

Published in: Tropical medicine & international health : TM & IH (2023)

Thicker baseline central macular thickness and presence of subretinal fluid were the factors significantly associated with greater changes of central macular thickness in diabetic macular oedema patients after receiving three injections of intravitreal ranibizumab.

Keyphrases

diabetic retinopathy
optical coherence tomography
age related macular degeneration
end stage renal disease
newly diagnosed
ejection fraction
type diabetes
prognostic factors
peritoneal dialysis
cataract surgery
ultrasound guided
platelet rich plasma